Artificial intelligence (AI) continues to push the boundaries of scientific research and revolutionize the field of medicine. One groundbreaking area where AI has made remarkable contributions is in the development of anti-aging drugs. Researchers from the University of Edinburgh, utilizing AI technology, have recently identified three chemicals that specifically target malfunctioning cells associated with certain cancers and Alzheimer’s disease.
The team of scientists developed an AI algorithm to screen a vast collection of over 4,300 chemical compounds with the goal of finding potential anti-aging drugs, commonly known as senolytic drugs. These medications are designed to induce the death of senescent cells, which are defective cells that cease to multiply but persist in the body instead of dying off. These cells continue to discharge chemicals that stimulate inflammation, leading to various health problems.
After analyzing the dataset, the AI algorithm identified 21 candidates for anti-aging and cell senescence. The researchers then narrowed
